Patents by Inventor Girolamo Calo'

Girolamo Calo' has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Supramolecular aggregates comprising maleimido cores
    Patent number: 9962447
    Abstract: The invention relates to a supramolecular aggregate of formula (VI) wherein A is an active substance, and X1, X2, X3 and X4, independently to each other, are a moiety of Formula (I) containing a maleimido functionalization and at least one among X1, X2, X3 and X4 is present in Formula (VI). In a preferred embodiment the maleimido-functionalized core is PWT2. The supra-molecular aggregate can be used in the field of drugs, vaccines, as ligands for GPCR, i.e. agonists as well as antagonist, as antibiotics and as diagnostics eventually in complex with radionuclides.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: May 8, 2018
    Assignee: UFPEPTIDES S.R.L.
    Inventors: Remo Guerrini, Severo Salvadori, Girolamo Calo′
  • SUPRAMOLECULAR AGGREGATES COMPRISING MALEIMIDO CORES
    Publication number: 20160051689
    Abstract: The invention relates to a supramolecular aggregate of formula (VI) wherein A is an active substance, and X1, X2, X3 and X4, independently to each other, are a moiety of Formula (I) containing a maleimido functionalization and at least one among X1, X2, X3 and X4 is present in Formula (VI). In a preferred embodiment the maleimido-funzionalized core is PWT2. The supra-molecular aggregate can be used in the field of drugs, vaccines, as ligands for GPCR, i.e. agonists as well as antagonist, as antibiotics and as diagnostics eventually in complex with radionuclides.
    Type: Application
    Filed: April 3, 2014
    Publication date: February 25, 2016
    Applicant: UFPEPTIDES S.R.L.
    Inventors: Remo GUERRINI, Severo SALVADORI, Girolamo CALO'
  • Highly potent full and partial agonists and antagonists of the nociceptin/orphanin FQ receptor
    Patent number: 8227414
    Abstract: Peptide analogs of nociceptin/orphanin FQ, compositions thereof, and their use in treatment of disorders and dysfunctions related to activation or blocking of NOP receptors are described.
    Type: Grant
    Filed: February 15, 2006
    Date of Patent: July 24, 2012
    Assignee: UFPEPTIDES S.R.L.
    Inventors: Remo Guerrini, Severo Salvadori, Girolamo Calo', Domenico Regoli
  • Highly Potent Full and Partial Agonists and Antagonists of the Nociceptin/Orphanin FQ Receptor
    Publication number: 20100273710
    Abstract: Peptide analogs of nociceptin/orphanin FQ, compositions thereof, and their use in treatment of disorders and dysfunctions related to activation or blocking of NOP receptors are described.
    Type: Application
    Filed: February 15, 2006
    Publication date: October 28, 2010
    Inventors: Remo Guerrini, Severo Salvadori, Girolamo Calo', Domenico Regoli
  • Analogs of nocicettin
    Publication number: 20040122013
    Abstract: Peptide analogs of nociceptin, pharmaceutical composition containing thereof and their use in the treatment of disorders and/or phatological conditions where is useful a NOP receptors activation are described.
    Type: Application
    Filed: September 24, 2003
    Publication date: June 24, 2004
    Inventors: Remo Guerrini, Girolamo Calo, Severo Salvadori, Domenico Regoli